MiMedx Group, Inc. Net Income (Loss) Available to Common Stockholders, Diluted
MiMedx Group, Inc. (MDXG) reported Net Income (Loss) Available to Common Stockholders, Diluted of $6.76 million for the 3-month period ending 2023-09-30, per its 10-Q filed 2023-10-30.
Discontinued › Income Statement › Net Income
us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted · last filed 2023-10-30
- MiMedx Group, Inc. net income (loss) available to common stockholders, diluted for the quarter ending 2023-09-30 was $6.76M.
- MiMedx Group, Inc. net income (loss) available to common stockholders, diluted for the quarter ending 2023-06-30 was -$528.00K.
- MiMedx Group, Inc. net income (loss) available to common stockholders, diluted for the quarter ending 2023-03-31 was -$6.67M.
- MiMedx Group, Inc. net income (loss) available to common stockholders, diluted for the quarter ending 2022-12-31 was -$2.11M, a 441.42% decline year-over-year.
- MiMedx Group, Inc. net income (loss) available to common stockholders, diluted for fiscal 2022 was -$36.78M.
- MiMedx Group, Inc. net income (loss) available to common stockholders, diluted for fiscal 2021 was -$16.42M.
- MiMedx Group, Inc. net income (loss) available to common stockholders, diluted for fiscal 2020 was -$83.33M.
- MiMedx Group, Inc. net income (loss) available to common stockholders, diluted for fiscal 2019 was -$25.58M.
| Period end | Net Income (Loss) Available to Common Stockholders, Diluted 3 month | Net Income (Loss) Available to Common Stockholders, Diluted 6 month | Net Income (Loss) Available to Common Stockholders, Diluted 9 month | Net Income (Loss) Available to Common Stockholders, Diluted 12 month |
|---|---|---|---|---|
| 2023-09-30 | $6.76M 10-Q · filed 2023-10-30 | $6.23M derived: sum of 2 quarters · filed 2023-10-30 | -$433.00K 10-Q · filed 2023-10-30 | -$2.54M derived: sum of 4 quarters · filed 2023-10-30 |
| 2023-06-30 | -$528.00K 10-Q · filed 2023-08-01 | -$7.19M 10-Q · filed 2023-08-01 | -$9.30M derived: sum of 3 quarters · filed 2023-08-01 | -$19.40M derived: sum of 4 quarters · filed 2023-10-30 |
| 2023-03-31 | -$6.67M 10-Q · filed 2023-05-02 | -$8.78M derived: sum of 2 quarters · filed 2023-05-02 | -$18.87M derived: sum of 3 quarters · filed 2023-10-30 | -$31.37M derived: sum of 4 quarters · filed 2023-10-30 |
| 2022-12-31 | -$2.11M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | -$12.21M derived: sum of 2 quarters · filed 2023-10-30 | -$24.70M derived: sum of 3 quarters · filed 2023-10-30 | -$36.78M 10-K · filed 2023-02-28 |
| 2022-09-30 | -$10.10M 10-Q · filed 2023-10-30 | -$22.59M derived: sum of 2 quarters · filed 2023-10-30 | -$34.67M 10-Q · filed 2023-10-30 | -$34.05M derived: sum of 4 quarters · filed 2023-10-30 |
| 2022-06-30 | -$12.50M 10-Q · filed 2023-08-01 | -$24.57M 10-Q · filed 2023-08-01 | -$23.95M derived: sum of 3 quarters · filed 2023-08-01 | -$27.87M derived: sum of 4 quarters · filed 2023-08-01 |
| 2022-03-31 | -$12.07M 10-Q · filed 2023-05-02 | -$11.46M derived: sum of 2 quarters · filed 2023-05-02 | -$15.37M derived: sum of 3 quarters · filed 2023-05-02 | |
| 2021-12-31 | $618.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | -$3.29M derived: sum of 2 quarters · filed 2023-02-28 | -$16.42M 10-K · filed 2023-02-28 | |
| 2021-09-30 | -$3.91M 10-Q · filed 2022-11-02 | -$17.04M 10-Q · filed 2022-11-02 | ||
| 2020-12-31 | -$18.06M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | -$70.04M derived: sum of 2 quarters · filed 2023-02-28 | -$83.33M 10-K · filed 2023-02-28 | |
| 2020-09-30 | -$51.98M 10-Q · filed 2020-11-04 | -$65.27M 10-Q · filed 2020-11-04 | ||
| 2019-12-31 | -$7.48M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-08 | $4.90M derived: sum of 2 quarters · filed 2021-03-08 | -$25.58M 10-K · filed 2021-03-08 | |
| 2019-09-30 | $12.38M 10-Q · filed 2020-11-04 | -$18.10M 10-Q · filed 2020-11-04 | ||
| 2018-12-31 | -$29.98M 10-K · filed 2021-03-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B | |
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| NeuroPace Inc (NPCE) | United States | $0.480B | -28.52 |
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B |